| Category: |
Proteins And Peptides |
| Antibody's target: |
Human CITED1 Protein |
| Immunogen: |
See techfile |
| Reactivity: |
Mouse, Rat, Human |
| Purification: |
Affinity purified |
| Applications: |
WB (for other see techfile or inquire) |
| Stock availability: |
Shipped within 5-12 working days |
| Storage conditions: |
Avoid repeated freeze/thaw cycles, Aliquot and store at -20 °, C |
| Warnings: |
This product is for research use only |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| Source: |
proteins, Recombinants or rec |
| Group: |
recombinants |
| Gene target: |
CITED1 Protein |
| Short name: |
Anti- CITED1 Protein (Recombinant) |
| Technique: |
E, abbex advises they will be reconstituted in a buffer soluion or culture medium for cell culture, coli recombinant proteins are , supplied as white sterile powder lyopillized, Recombinant, genetic recombinations , in Escherichia coli |
| Species: |
Humans, Human |
| Alternative name: |
1 Protein (recombinant), including L-gutamic acid/L-aspartic acid-rich carboxy-terminal domain, sapiens Cbp/p300-interacting transactivator, antibody to-H |
| Alternative technique: |
rec |
| Alternative to gene target: |
1, CITED1 and IDBG-635694 and ENSBTAG00000045925 and 282182, CITED1 and IDBG-76674 and ENSG00000125931 and 4435, Cited1 and IDBG-164976 and ENSMUSG00000051159 and 12705, DNA-templated and biological process this GO :0006355 and regulation of transcription, DNA-templated and biological process this GO :0006357 and regulation of transcription from RNA polymerase II promoter and biological process this GO :0006913 and nucleocytoplasmic transport and biological process this GO :0006915 and apoptotic process and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0007420 and brain development and biological process this GO :0008022 and protein C-terminus binding and molecular function this GO :0008283 and cell proliferation and biological process this GO :0010628 and positive regulation of gene expression and biological process this GO :0030178 and negative regulation of Wnt signaling pathway and biological process this GO :0030318 and melanocyte differentiation and biological process this GO :0030511 and positive regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0032496 and response to lipopolysaccharide and biological process this GO :0032868 and response to insulin and biological process this GO :0034097 and response to cytokine and biological process this GO :0034341 and response to interferon-gamma and biological process this GO :0042438 and melanin biosynthetic process and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043473 and pigmentation and biological process this GO :0043524 and negative regulation of neuron apoptotic process and biological process this GO :0043627 and response to estrogen and biological process this GO :0044212 and transcription regulatory region DNA binding and molecular function this GO :0045668 and negative regulation of osteoblast differentiation and biological process this GO :0045892 and negative regulation of transcription, DNA-templated and biological process this GO :0045893 and positive regulation of transcription, DNA-templated and biological process this GO :0050693 and LBD domain binding and molecular function this GO :0051591 and response to cAMP and biological process this GO :0060231 and mesenchymal to epithelial transition and biological process this GO :0060395 and SMAD protein signal transduction and biological process this GO :0060711 and labyrinthine layer development and biological process this GO :0060712 and spongiotrophoblast layer development and biological process this GO :0070410 and co-SMAD binding and molecular function this GO :0070555 and response to interleukin-1 and biological process this GO :0070669 and response to interleukin-2 and biological process this GO :0070670 and response to interleukin-4 and biological process this GO :0070741 and response to interleukin-6 and biological process this GO :0071104 and response to interleukin-9 and biological process this GO :0071105 and response to interleukin-11 and biological process this GO :0071107 and response to parathyroid hormone and biological process this GO :0071559 and response to transforming growth factor beta and biological process, MSG1, co-SMAD binding, nuclei, this GO :0000578 and embryonic axis specification and biological process this GO :0001570 and vasculogenesis and biological process this GO :0001656 and metanephros development and biological process this GO :0001658 and branching involved in ureteric bud morphogenesis and biological process this GO :0001890 and placenta development and biological process this GO :0003340 and negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis and biological process this GO :0003682 and chromatin binding and molecular function this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0003713 and transcription coactivator activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0006351 and transcription, this GO :0003682 : chromatin binding, this GO :0003682 : chromatin binding and also this GO :0003700 : sequence-specific DNA binding transcription factor activity and also this GO :0003713 : transcription coactivator activity and also this GO :0005515 : protein binding and also this GO :0008022 : protein C-terminus binding and also this GO :0042803 : protein homodimerization activity and also this GO :0044212 : transcription regulatory region DNA binding and also this GO :0050693 : LBD domain binding and also this GO :0070410 : co-SMAD binding, this GO :0003700 : sequence-specific DNA binding transcription factor activity, this GO :0003713 : transcription coactivator activity, this GO :0005515 : protein binding, this GO :0008022 : protein C-terminus binding, this GO :0042803 : protein homodimerization activity, this GO :0044212 : transcription regulatory region DNA binding, this GO :0050693 : LBD domain binding, this GO :0070410 : co-SMAD binding, with Glu/Asp-rich carboxy-terminal domain, Cbp/p300-interacting transactivator |
| Identity: |
1986 |
| Gene: |
CITED1 |
More about : CITED1 |
| Long gene name: |
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1 |
| Synonyms gene: |
MSG1 |
| Synonyms gene name: |
1 , Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain |
| Locus: |
Xq13, 1 |
| Discovery year: |
1998-03-27 |
| GenBank acession: |
U65092 |
| Entrez gene record: |
4435 |
| Pubmed identfication: |
8901575 9721210 |
| RefSeq identity: |
NM_004143 |
| Havana BLAST/BLAT: |
OTTHUMG00000021812 |
| Locus Specific Databases: |
Mental Retardation database |